RedHill Biopharma Ltd. logo
RedHill Biopharma Ltd. RDHL
$ 6.7 3.63%

Annual report 2023
added 11-09-2024

report update icon

RedHill Biopharma Ltd. Income Statement 2011-2024 | RDHL

Annual Income Statement RedHill Biopharma Ltd.

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

- - 1.2 B 310 M 1.8 B 1.28 B 908 M 1.24 B 1.1 B 130 M 78.7 M 57.9 M -

Shares

- - 465 M 38.4 M 297 M 231 M 177 M 129 M 111 M 8.66 M 6.24 M 5.26 M -

Historical Prices

0.43 0.92 2.58 8.08 6.07 5.55 5.14 10.5 12.9 13.3 11.8 - -

Net Income

- - -97.7 M -76.2 M -42.3 M -38.8 M -45.5 M -29.4 M -21.1 M -10.7 M -10.6 M -10.3 M -15.5 M

Revenue

6.53 M 61.8 M 85.8 M 64.4 M 6.29 M 8.36 M 4.01 M 101 K 3 K 7.01 M 12 K 16 K 23 K

Cost of Revenue

- - 49.4 M 36.9 M 2.26 M 2.84 M 2.13 M - - - - - -

Gross Profit

3.07 M 28.5 M 36.4 M 27.5 M 4.03 M 5.52 M 1.88 M 101 K 3 K 5.96 M 12 K 16 K -

Operating Income

- - -81.1 M -63.7 M -43.2 M -39.3 M -52 M -30.5 M -22 M - - - -

Interest Expense

- - - - - - - - - - - - -

EBITDA

- - -81.1 M -63.7 M -43.2 M -39.3 M -52 M -30.5 M -22 M -10.6 M -10.7 M -9.02 M -7.86 M

Operating Expenses

- - - 91.2 M 47.2 M 44.9 M 53.9 M 30.6 M 22 M 16.6 M 10.8 M 9.06 M -

General and Administrative Expenses

- - 32.4 M 66.6 M 29.8 M 20 M 20 M 5.4 M 4.13 M 4.01 M 2.68 M 2.6 M 2.48 M

All numbers in USD currency

Quarterly Income Statement RedHill Biopharma Ltd.

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- - - - - - 467 M - - - 358 M - - - 284 M - - - 213 M - - - 172 M - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

- - - - - - -29.1 M - - - -16 M - - - -10.9 M - - - -11.1 M - - - -11 M - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - 21.5 M - - - 20.9 M - - - 1.56 M - - - 2.35 M - - - 483 K - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - 10.6 M - - - 14.2 M - - - 425 K - - - 725 K - - - 272 K - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - 10.9 M - - - 6.71 M - - - 1.14 M - - - 1.62 M - - - 211 K - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- - - - - - -24.9 M - - - -12.5 M - - - -12.4 M - - - -9.56 M - - - -13.5 M - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - - - - - -24.9 M - - - -12.5 M - - - -12.4 M - - - -9.56 M - - - -13.5 M - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

- - - - - - 10.2 M - - - 6.03 M - - - 2.4 M - - - 2.02 M - - - 1.94 M - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency